As of April 15, 2025, Biotest (BIO.F) has a market cap of $1.59 billion USD. According to our data, Biotest is ranked No.4335 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $1.59 B |
73.28%
|
Dec 30, 2024 | $0.92 B |
-3.30%
|
Dec 29, 2023 | $0.95 B |
-0.93%
|
Dec 30, 2022 | $0.96 B |
0.94%
|
Dec 30, 2021 | $0.95 B |
47.22%
|
Dec 30, 2020 | $0.64 B |
50.39%
|
Dec 30, 2019 | $0.43 B |
-26.08%
|
Dec 28, 2018 | $0.58 B |
14.99%
|
Dec 29, 2017 | $0.50 B |
39.95%
|
Dec 30, 2016 | $0.36 B |
-12.04%
|
Dec 30, 2015 | $0.41 B |
-36.70%
|
Dec 30, 2014 | $0.65 B |
13.89%
|
Dec 30, 2013 | $0.57 B |
55.36%
|
Dec 28, 2012 | $0.37 B |
24.65%
|
Dec 30, 2011 | $0.29 B |
-14.91%
|
Dec 30, 2010 | $0.34 B |
24.68%
|
Dec 30, 2009 | $0.28 B |
-28.62%
|
Dec 30, 2008 | $0.39 B |
42.30%
|
Dec 28, 2007 | $0.27 B |
29.83%
|
Dec 29, 2006 | $0.21 B |
20.65%
|
Dec 30, 2005 | $0.17 B |
103.75%
|
Dec 31, 2004 | $85.25 M |
64.38%
|
Dec 31, 2003 | $51.86 M |
48.98%
|
Dec 31, 2002 | $34.81 M |
-63.43%
|
Dec 31, 2001 | $95.20 M |
-11.26%
|
Dec 29, 2000 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
![]() Australia
|
![]() Grifols
GRFS
|
$5.71 B |
3.909 B
|
![]() Spain
|
![]() Baxter
BAX
|
$14.26 B |
0.000 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Kamada
KMDA
|
$0.36 B |
-0.000 M
|
![]() Israel
|
![]() ADMA Biologics
ADMA
|
$5.26 B |
-0.000 M
|
![]() USA
|
![]() Biolife Solutions
BLFS
|
$1.07 B |
0.000 M
|
![]() USA
|
![]() Emergent BioSolutions
EBS
|
$0.25 B |
0.000 M
|
![]() USA
|
![]() Haemonetics
HAE
|
$2.93 B |
0.000 M
|
![]() USA
|
![]() Cerus
CERS
|
$0.25 B |
-0.000 M
|
![]() USA
|
Market Cap | = | BIO.F Stock Price | * | BIO.F Shares Outstanding |
= | $47.47 | * | 19.79 M | |
= | $1.59 B |